![T1E T1E](https://data.pdbj.org/pdbjplus/data/cc/svg/T1E.svg) | T1E | Name: | 1-[1-(3,5-dimethoxyphenyl)piperidin-4-yl]-2,3-dimethyl-guanidine | Formula: | C16 H26 N4 O2 | SMILES: | CNC(NC1CCN(CC1)c2cc(OC)cc(OC)c2)=NC | InChi: | InChI=1S/C16H26N4O2/c1-17-16(18-2)19-12-5-7-20(8-6-12)13-9-14(21-3)11-15(10-13)22-4/h9-12H,5-8H2,1-4H3,(H2,17,18,19) | Definition date: | 2020-12-10 | Last modified: | 2021-10-15 | Release date: | 2021-10-20 | Identifier: | 1-[1-(3,5-dimethoxyphenyl)piperidin-4-yl]-2,3-dimethyl-guanidine |
|
![T1H T1H](https://data.pdbj.org/pdbjplus/data/cc/svg/T1H.svg) | T1H | Name: | 2-[4-[[(~{E})-~{N},~{N}'-dimethylcarbamimidoyl]amino]piperidin-1-yl]-~{N}-[[2-(3-methyl-1,2,3-triazol-4-yl)-1~{H}-benzimidazol-5-yl]methyl]ethanamide | Formula: | C21 H30 N10 O | SMILES: | CNC(NC1CCN(CC1)CC(=O)NCc2ccc3[nH]c(nc3c2)c4cnnn4C)=NC | InChi: | InChI=1S/C21H30N10O/c1-22-21(23-2)26-15-6-8-31(9-7-15)13-19(32)24-11-14-4-5-16-17(10-14)28-20(27-16)18-12-25-29-30(18)3/h4-5,10,12,15H,6-9,11,13H2,1-3H3,(H,24,32)(H,27,28)(H2,22,23,26) | Definition date: | 2020-12-10 | Last modified: | 2021-10-15 | Release date: | 2021-10-20 | Identifier: | 2-[4-[[(~{E})-~{N},~{N}'-dimethylcarbamimidoyl]amino]piperidin-1-yl]-~{N}-[[2-(3-methyl-1,2,3-triazol-4-yl)-1~{H}-benzimidazol-5-yl]methyl]ethanamide |
|
![T3H T3H](https://data.pdbj.org/pdbjplus/data/cc/svg/T3H.svg) | T3H | Name: | (2~{S})-1-[4-[[(~{E})-~{N},~{N}'-dimethylcarbamimidoyl]amino]phenyl]-~{N}-[[2-(3-methyl-1,2,3-triazol-4-yl)-1~{H}-benzimidazol-5-yl]methyl]pyrrolidine-2-carboxamide | Formula: | C25 H30 N10 O | SMILES: | CNC(Nc1ccc(cc1)N2CCC[CH]2C(=O)NCc3ccc4[nH]c(nc4c3)c5cnnn5C)=NC | InChi: | InChI=1S/C25H30N10O/c1-26-25(27-2)30-17-7-9-18(10-8-17)35-12-4-5-21(35)24(36)28-14-16-6-11-19-20(13-16)32-23(31-19)22-15-29-33-34(22)3/h6-11,13,15,21H,4-5,12,14H2,1-3H3,(H,28,36)(H,31,32)(H2,26,27,30)/t21-/m0/s1 | Definition date: | 2020-12-14 | Last modified: | 2021-10-15 | Release date: | 2021-10-20 | Identifier: | (2~{S})-1-[4-[[(~{E})-~{N},~{N}'-dimethylcarbamimidoyl]amino]phenyl]-~{N}-[[2-(3-methyl-1,2,3-triazol-4-yl)-1~{H}-benzimidazol-5-yl]methyl]pyrrolidine-2-carboxamide |
|
![T8W T8W](https://data.pdbj.org/pdbjplus/data/cc/svg/T8W.svg) | T8W | Name: | 4-[[49,50,51,52,53,54,55,56-octahydroxy-11,17,23,29,35,41,47-heptakis[(4-sulfonatophenyl)methyl]-5-nonacyclo[43.3.1.13,7.19,13.115,19.121,25.127,31.133,37.139,43]hexapentaconta-1(49),3,5,7(56),9,11,13(55),15,17,19(54),21,23,25(53),27,29,31(52),33,35,37(51),39,41,43(50),45,47-tetracosaenyl]methyl]benzenesulfonate | Formula: | C112 H88 O32 S8 | SMILES: | Oc1c2Cc3cc(Cc4ccc(cc4)[S]([O-])(=O)=O)cc(Cc5cc(Cc6ccc(cc6)[S]([O-])(=O)=O)cc(Cc7cc(Cc8ccc(cc8)[S]([O-])(=O)=O)cc(Cc9cc(Cc%10ccc(cc%10)[S]([O-])(=O)=O)cc(Cc%11cc(Cc%12ccc(cc%12)[S]([O-])(=O)=O)cc(Cc%13cc(Cc%14ccc(cc%14)[S]([O-])(=O)=O)cc(Cc%15cc(Cc%16ccc(cc%16)[S]([O-])(=O)=O)cc(Cc1cc(Cc%17ccc(cc%17)[S]([O-])(=O)=O)c2)c%15O)c%13O)c%11O)c9O)c7O)c5O)c3O | InChi: | InChI=1S/C112H96O32S8/c113-105-81-41-73(33-65-1-17-97(18-2-65)145(121,122)123)42-82(105)58-84-44-75(35-67-5-21-99(22-6-67)147(127,128)129)46-86(107(84)115)60-88-48-77(37-69-9-25-101(26-10-69)149(133,134)135)50-90(109(88)117)62-92-52-79(39-71-13-29-103(30-14-71)151(139,140)141)54-94(111(92)119)64-96-56-80(40-72-15-31-104(32-16-72)152(142,143)144)55-95(112(96)120)63-93-53-78(38-70-11-27-102(28-12-70)150(136,137)138)51-91(110(93)118)61-89-49-76(36-68-7-23-100(24-8-68)148(130,131)132)47-87(108(89)116)59-85-45-74(43-83(57-81)106(85)114)34-66-3-19-98(20-4-66)146(124,125)126/h1-32,41-56,113-120H,33-40,57-64H2,(H,121,122,123)(H,124,125,126)(H,127,128,129)(H,130,131,132)(H,133,134,135)(H,136,137,138)(H,139,140,141)(H,142,143,144)/p-8 | Synonyms: | p-benzyl-sulfonato-calix[8]arene-PEG pseudorotaxane | Definition date: | 2020-12-18 | Last modified: | 2021-10-15 | Release date: | 2021-10-20 |
|
![T8Z T8Z](https://data.pdbj.org/pdbjplus/data/cc/svg/T8Z.svg) | T8Z | Name: | 2-(1-methyl-1H-1,2,3-triazol-5-yl)-5-((2-(pyridin-4-yl)pyrrolidin-1-yl)methyl)-1H-benzo[d]imidazole | Formula: | C20 H21 N7 | SMILES: | Cn1nncc1c2[nH]c3cc(CN4CCC[CH]4c5ccncc5)ccc3n2 | InChi: | InChI=1S/C20H21N7/c1-26-19(12-22-25-26)20-23-16-5-4-14(11-17(16)24-20)13-27-10-2-3-18(27)15-6-8-21-9-7-15/h4-9,11-12,18H,2-3,10,13H2,1H3,(H,23,24)/t18-/m0/s1 | Synonyms: | 2-(3-methyl-1,2,3-triazol-4-yl)-6-[[(2~{S})-2-pyridin-4-ylpyrrolidin-1-yl]methyl]-1~{H}-benzimidazole | Definition date: | 2020-12-18 | Last modified: | 2021-10-15 | Release date: | 2021-10-20 | Identifier: | 2-(3-methyl-1,2,3-triazol-4-yl)-6-[[(2~{S})-2-pyridin-4-ylpyrrolidin-1-yl]methyl]-1~{H}-benzimidazole |
|
![Y1W Y1W](https://data.pdbj.org/pdbjplus/data/cc/svg/Y1W.svg) | Y1W | Name: | (1S)-2-[(2r,5S)-5-{[(2,3-dihydro-1,4-benzodioxin-6-yl)methyl]amino}-1,3-dioxan-2-yl]-1-(3-fluoro-6-methoxyquinolin-4-yl)ethan-1-ol | Formula: | C25 H27 F N2 O6 | SMILES: | OC(CC1OCC(CO1)NCc1ccc2OCCOc2c1)c1c2cc(OC)ccc2ncc1F | InChi: | InChI=1S/C25H27FN2O6/c1-30-17-3-4-20-18(9-17)25(19(26)12-28-20)21(29)10-24-33-13-16(14-34-24)27-11-15-2-5-22-23(8-15)32-7-6-31-22/h2-5,8-9,12,16,21,24,27,29H,6-7,10-11,13-14H2,1H3/t16-,21-,24-/m0/s1 | Definition date: | 2021-05-26 | Last modified: | 2021-10-15 | Release date: | 2021-10-20 | Identifier: | (1S)-2-[(2r,5S)-5-{[(2,3-dihydro-1,4-benzodioxin-6-yl)methyl]amino}-1,3-dioxan-2-yl]-1-(3-fluoro-6-methoxyquinolin-4-yl)ethan-1-ol |
|
![ZFY ZFY](https://data.pdbj.org/pdbjplus/data/cc/svg/ZFY.svg) | ZFY | Name: | 2-{2-[(cyclopropanesulfonyl)amino]-1,3-thiazol-4-yl}-2-methyl-N-{5-[6-(trifluoromethyl)pyrazin-2-yl]pyridin-2-yl}propanamide | Formula: | C20 H19 F3 N6 O3 S2 | SMILES: | O=S(=O)(Nc1nc(cs1)C(C)(C)C(=O)Nc1ccc(cn1)c1cncc(n1)C(F)(F)F)C1CC1 | InChi: | InChI=1S/C20H19F3N6O3S2/c1-19(2,15-10-33-18(27-15)29-34(31,32)12-4-5-12)17(30)28-16-6-3-11(7-25-16)13-8-24-9-14(26-13)20(21,22)23/h3,6-10,12H,4-5H2,1-2H3,(H,27,29)(H,25,28,30) | Definition date: | 2021-04-19 | Last modified: | 2021-10-08 | Release date: | 2021-10-13 | Identifier: | 2-{2-[(cyclopropanesulfonyl)amino]-1,3-thiazol-4-yl}-2-methyl-N-{5-[6-(trifluoromethyl)pyrazin-2-yl]pyridin-2-yl}propanamide |
|
![ZG4 ZG4](https://data.pdbj.org/pdbjplus/data/cc/svg/ZG4.svg) | ZG4 | Name: | N-(1-{2-[(cyclopropanesulfonyl)amino]-1,3-thiazol-4-yl}cyclopropyl)-5-(6-ethoxypyrazin-2-yl)pyridine-2-carboxamide | Formula: | C21 H22 N6 O4 S2 | SMILES: | O=S(=O)(Nc1nc(cs1)C1(NC(=O)c2ccc(cn2)c2cncc(OCC)n2)CC1)C1CC1 | InChi: | InChI=1S/C21H22N6O4S2/c1-2-31-18-11-22-10-16(24-18)13-3-6-15(23-9-13)19(28)26-21(7-8-21)17-12-32-20(25-17)27-33(29,30)14-4-5-14/h3,6,9-12,14H,2,4-5,7-8H2,1H3,(H,25,27)(H,26,28) | Definition date: | 2021-04-19 | Last modified: | 2021-10-08 | Release date: | 2021-10-13 | Identifier: | N-(1-{2-[(cyclopropanesulfonyl)amino]-1,3-thiazol-4-yl}cyclopropyl)-5-(6-ethoxypyrazin-2-yl)pyridine-2-carboxamide |
|
![5LV 5LV](https://data.pdbj.org/pdbjplus/data/cc/svg/5LV.svg) | 5LV | Name: | 8-[[1-(3-azanylpropyl)piperidin-4-yl]amino]-5-[5-(hydroxymethyl)pyridin-3-yl]-3-methyl-1~{H}-1,7-naphthyridin-2-one | Formula: | C23 H30 N6 O2 | SMILES: | CC1=Cc2c(NC1=O)c(NC3CCN(CCCN)CC3)ncc2c4cncc(CO)c4 | InChi: | InChI=1S/C23H30N6O2/c1-15-9-19-20(17-10-16(14-30)11-25-12-17)13-26-22(21(19)28-23(15)31)27-18-3-7-29(8-4-18)6-2-5-24/h9-13,18,30H,2-8,14,24H2,1H3,(H,26,27)(H,28,31) | Synonyms: | 8-((1-(3-aminopropyl)piperidin-4-yl)amino)-5-(5-(hydroxymethyl)pyridin-3-yl)-3-methyl-1,7-naphthyridin-2(1H)-one | Definition date: | 2021-07-13 | Last modified: | 2021-10-08 | Release date: | 2021-10-13 | Identifier: | 8-[[1-(3-azanylpropyl)piperidin-4-yl]amino]-5-[5-(hydroxymethyl)pyridin-3-yl]-3-methyl-1~{H}-1,7-naphthyridin-2-one |
|
![HZX HZX](https://data.pdbj.org/pdbjplus/data/cc/svg/HZX.svg) | HZX | Name: | 2-[[6-[(4-nitrophenyl)amino]-3-oxidanyl-pyridin-2-yl]carbonylamino]ethanoic acid | Formula: | C14 H12 N4 O6 | SMILES: | OC(=O)CNC(=O)c1nc(Nc2ccc(cc2)[N+]([O-])=O)ccc1O | InChi: | InChI=1S/C14H12N4O6/c19-10-5-6-11(17-13(10)14(22)15-7-12(20)21)16-8-1-3-9(4-2-8)18(23)24/h1-6,19H,7H2,(H,15,22)(H,16,17)(H,20,21) | Definition date: | 2021-03-06 | Last modified: | 2021-10-08 | Release date: | 2021-10-13 | Identifier: | 2-[[6-[(4-nitrophenyl)amino]-3-oxidanyl-pyridin-2-yl]carbonylamino]ethanoic acid |
|
![0H0 0H0](https://data.pdbj.org/pdbjplus/data/cc/svg/0H0.svg) | 0H0 | Name: | Carbohydrate component from a pentavalent N-acetylneuraminic acid conjugate | Formula: | C15 H27 N O9 | SMILES: | CCCCO[C]1(C[CH](O)[CH](NC(C)=O)[CH](O1)[CH](O)[CH](O)CO)C(O)=O | InChi: | InChI=1S/C15H27NO9/c1-3-4-5-24-15(14(22)23)6-9(19)11(16-8(2)18)13(25-15)12(21)10(20)7-17/h9-13,17,19-21H,3-7H2,1-2H3,(H,16,18)(H,22,23)/t9-,10+,11+,12+,13+,15+/m0/s1 | Synonyms: | (1R,2R)-1-[(2R,3R,4S,6R)-6-[bis(oxidanyl)methyl]-3-(1-hydroxyethylamino)-4-oxidanyl-6-propoxy-oxan-2-yl]propane-1,2,3-triol | Definition date: | 2021-06-05 | Last modified: | 2021-10-08 | Release date: | 2021-10-13 | Identifier: | (2~{R},4~{S},5~{R},6~{R})-5-acetamido-2-butoxy-4-oxidanyl-6-[(1~{R},2~{R})-1,2,3-tris(oxidanyl)propyl]oxane-2-carboxylic acid |
|
![QWB QWB](https://data.pdbj.org/pdbjplus/data/cc/svg/QWB.svg) | QWB | Name: | 3-(imidazol-1-ylmethyl)-1~{H}-indole | Formula: | C12 H11 N3 | SMILES: | C(n1ccnc1)c2c[nH]c3ccccc23 | InChi: | InChI=1S/C12H11N3/c1-2-4-12-11(3-1)10(7-14-12)8-15-6-5-13-9-15/h1-7,9,14H,8H2 | Synonyms: | Cpd1 | Definition date: | 2020-08-14 | Last modified: | 2021-10-08 | Release date: | 2021-10-13 | Identifier: | 3-(imidazol-1-ylmethyl)-1~{H}-indole |
|
![QWH QWH](https://data.pdbj.org/pdbjplus/data/cc/svg/QWH.svg) | QWH | Name: | ~{N}-(3-bromanyl-2,6-dimethyl-pyridin-4-yl)propanamide | Formula: | C10 H13 Br N2 O | SMILES: | CCC(=O)Nc1cc(C)nc(C)c1Br | InChi: | InChI=1S/C10H13BrN2O/c1-4-9(14)13-8-5-6(2)12-7(3)10(8)11/h5H,4H2,1-3H3,(H,12,13,14) | Synonyms: | RA399 | Definition date: | 2020-08-14 | Last modified: | 2021-10-08 | Release date: | 2021-10-13 | Identifier: | ~{N}-(3-bromanyl-2,6-dimethyl-pyridin-4-yl)propanamide |
|
![QWK QWK](https://data.pdbj.org/pdbjplus/data/cc/svg/QWK.svg) | QWK | Name: | ~{N}-[6-(phenylmethyl)-7,8-dihydro-5~{H}-pyrido[4,3-d]pyrimidin-2-yl]propanamide | Formula: | C17 H20 N4 O | SMILES: | CCC(=O)Nc1ncc2CN(CCc2n1)Cc3ccccc3 | InChi: | InChI=1S/C17H20N4O/c1-2-16(22)20-17-18-10-14-12-21(9-8-15(14)19-17)11-13-6-4-3-5-7-13/h3-7,10H,2,8-9,11-12H2,1H3,(H,18,19,20,22) | Synonyms: | RA303 | Definition date: | 2020-08-14 | Last modified: | 2021-10-08 | Release date: | 2021-10-13 | Identifier: | ~{N}-[6-(phenylmethyl)-7,8-dihydro-5~{H}-pyrido[4,3-d]pyrimidin-2-yl]propanamide |
|
![QY5 QY5](https://data.pdbj.org/pdbjplus/data/cc/svg/QY5.svg) | QY5 | Name: | ~{N}-[3-bromanyl-2-(2-methylimidazol-1-yl)pyridin-4-yl]-3-[[3-bromanyl-2-(2-methylimidazol-1-yl)pyridin-4-yl]-propanoyl-amino]propanamide | Formula: | C24 H24 Br2 N8 O2 | SMILES: | CCC(=O)N(CCC(=O)Nc1ccnc(n2ccnc2C)c1Br)c3ccnc(n4ccnc4C)c3Br | InChi: | InChI=1S/C24H24Br2N8O2/c1-4-20(36)34(18-6-9-30-24(22(18)26)33-14-11-28-16(33)3)12-7-19(35)31-17-5-8-29-23(21(17)25)32-13-10-27-15(32)2/h5-6,8-11,13-14H,4,7,12H2,1-3H3,(H,29,31,35) | Definition date: | 2020-08-20 | Last modified: | 2021-10-08 | Release date: | 2021-10-13 | Identifier: | ~{N}-[3-bromanyl-2-(2-methylimidazol-1-yl)pyridin-4-yl]-3-[[3-bromanyl-2-(2-methylimidazol-1-yl)pyridin-4-yl]-propanoyl-amino]propanamide |
|
![7GI 7GI](https://data.pdbj.org/pdbjplus/data/cc/svg/7GI.svg) | 7GI | Name: | Repotrectinib | Formula: | C18 H18 F N5 O2 | SMILES: | C[CH]1CNC(=O)c2cnn3ccc(N[CH](C)c4cc(F)ccc4O1)nc23 | InChi: | InChI=1S/C18H18FN5O2/c1-10-8-20-18(25)14-9-21-24-6-5-16(23-17(14)24)22-11(2)13-7-12(19)3-4-15(13)26-10/h3-7,9-11H,8H2,1-2H3,(H,20,25)(H,22,23)/t10-,11+/m0/s1 | Synonyms: | TPX-0005 | Definition date: | 2021-10-01 | Last modified: | 2021-10-08 | Release date: | 2021-10-13 |
|
![1OE 1OE](https://data.pdbj.org/pdbjplus/data/cc/svg/1OE.svg) | 1OE | Name: | 2-[2-[[4-(2-chlorophenyl)-1,3-thiazol-2-yl]carbamoyl]indol-1-yl]ethanoic acid | Formula: | C20 H14 Cl N3 O3 S | SMILES: | OC(=O)Cn1c2ccccc2cc1C(=O)Nc3scc(n3)c4ccccc4Cl | InChi: | InChI=1S/C20H14ClN3O3S/c21-14-7-3-2-6-13(14)15-11-28-20(22-15)23-19(27)17-9-12-5-1-4-8-16(12)24(17)10-18(25)26/h1-9,11H,10H2,(H,25,26)(H,22,23,27) | Definition date: | 2021-07-06 | Last modified: | 2021-10-08 | Release date: | 2021-10-13 | Identifier: | 2-[2-[[4-(2-chlorophenyl)-1,3-thiazol-2-yl]carbamoyl]indol-1-yl]ethanoic acid |
|
![6IF 6IF](https://data.pdbj.org/pdbjplus/data/cc/svg/6IF.svg) | 6IF | Name: | methyl 7-chloro-6,7,8-trideoxy-6-{[(4S,5aS,8S,8aR)-4-(2-methylpropyl)octahydro-2H-oxepino[2,3-c]pyrrole-8-carbonyl]amino}-1-thio-L-threo-alpha-D-galacto-octopyranoside | Formula: | C22 H39 Cl N2 O6 S | SMILES: | OC1C(O)C(O)C(OC1SC)C(NC(=O)C1NCC2CC(CC(C)C)CCOC21)C(C)Cl | InChi: | InChI=1S/C22H39ClN2O6S/c1-10(2)7-12-5-6-30-19-13(8-12)9-24-15(19)21(29)25-14(11(3)23)20-17(27)16(26)18(28)22(31-20)32-4/h10-20,22,24,26-28H,5-9H2,1-4H3,(H,25,29)/t11-,12-,13-,14+,15-,16-,17+,18+,19+,20+,22+/m0/s1 | Definition date: | 2021-08-06 | Last modified: | 2021-10-08 | Release date: | 2021-10-13 | Identifier: | methyl 7-chloro-6,7,8-trideoxy-6-{[(4S,5aS,8S,8aR)-4-(2-methylpropyl)octahydro-2H-oxepino[2,3-c]pyrrole-8-carbonyl]amino}-1-thio-L-threo-alpha-D-galacto-octopyranoside |
|
![HG6 HG6](https://data.pdbj.org/pdbjplus/data/cc/svg/HG6.svg) | HG6 | Name: | 4-chloranyl-9,10-bis(oxidanylidene)anthracene-2-carboxylic acid | Formula: | C15 H7 Cl O4 | SMILES: | OC(=O)c1cc(Cl)c2C(=O)c3ccccc3C(=O)c2c1 | InChi: | InChI=1S/C15H7ClO4/c16-11-6-7(15(19)20)5-10-12(11)14(18)9-4-2-1-3-8(9)13(10)17/h1-6H,(H,19,20) | Definition date: | 2021-01-08 | Last modified: | 2021-10-08 | Release date: | 2021-10-13 | Identifier: | 4-chloranyl-9,10-bis(oxidanylidene)anthracene-2-carboxylic acid |
|
![HH9 HH9](https://data.pdbj.org/pdbjplus/data/cc/svg/HH9.svg) | HH9 | Name: | 4-chloranyl-9-oxidanylidene-xanthene-2-carboxylic acid | Formula: | C14 H7 Cl O4 | SMILES: | OC(=O)c1cc(Cl)c2Oc3ccccc3C(=O)c2c1 | InChi: | InChI=1S/C14H7ClO4/c15-10-6-7(14(17)18)5-9-12(16)8-3-1-2-4-11(8)19-13(9)10/h1-6H,(H,17,18) | Definition date: | 2021-01-08 | Last modified: | 2021-10-08 | Release date: | 2021-10-13 | Identifier: | 4-chloranyl-9-oxidanylidene-xanthene-2-carboxylic acid |
|
![U6E U6E](https://data.pdbj.org/pdbjplus/data/cc/svg/U6E.svg) | U6E | Name: | 4-(6-azanyl-2-chloranyl-purin-9-yl)-~{N}-(4-methyl-1,3-thiazol-2-yl)cyclohexane-1-carboxamide | Formula: | C16 H18 Cl N7 O S | SMILES: | Cc1csc(NC(=O)[CH]2CC[CH](CC2)n3cnc4c(N)nc(Cl)nc34)n1 | InChi: | InChI=1S/C16H18ClN7OS/c1-8-6-26-16(20-8)23-14(25)9-2-4-10(5-3-9)24-7-19-11-12(18)21-15(17)22-13(11)24/h6-7,9-10H,2-5H2,1H3,(H2,18,21,22)(H,20,23,25)/t9-,10+ | Definition date: | 2021-01-25 | Last modified: | 2021-10-08 | Release date: | 2021-10-13 | Identifier: | 4-(6-azanyl-2-chloranyl-purin-9-yl)-~{N}-(4-methyl-1,3-thiazol-2-yl)cyclohexane-1-carboxamide |
|
![U6H U6H](https://data.pdbj.org/pdbjplus/data/cc/svg/U6H.svg) | U6H | Name: | 4-(6-azanyl-2-pyridin-4-yl-purin-9-yl)-~{N}-(3-methoxyphenyl)cyclohexane-1-carboxamide | Formula: | C24 H25 N7 O2 | SMILES: | COc1cccc(NC(=O)[CH]2CC[CH](CC2)n3cnc4c(N)nc(nc34)c5ccncc5)c1 | InChi: | InChI=1S/C24H25N7O2/c1-33-19-4-2-3-17(13-19)28-24(32)16-5-7-18(8-6-16)31-14-27-20-21(25)29-22(30-23(20)31)15-9-11-26-12-10-15/h2-4,9-14,16,18H,5-8H2,1H3,(H,28,32)(H2,25,29,30)/t16-,18+ | Definition date: | 2021-01-25 | Last modified: | 2021-10-08 | Release date: | 2021-10-13 | Identifier: | 4-(6-azanyl-2-pyridin-4-yl-purin-9-yl)-~{N}-(3-methoxyphenyl)cyclohexane-1-carboxamide |
|
![U6N U6N](https://data.pdbj.org/pdbjplus/data/cc/svg/U6N.svg) | U6N | Name: | (2~{R})-2-[[7-but-2-ynyl-5-(3-chloranyl-2-methyl-phenyl)-6-ethyl-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-3-phenyl-propanoic acid | Formula: | C28 H27 Cl N4 O2 | SMILES: | CCc1n(CC#CC)c2ncnc(N[CH](Cc3ccccc3)C(O)=O)c2c1c4cccc(Cl)c4C | InChi: | InChI=1S/C28H27ClN4O2/c1-4-6-15-33-23(5-2)24(20-13-10-14-21(29)18(20)3)25-26(30-17-31-27(25)33)32-22(28(34)35)16-19-11-8-7-9-12-19/h7-14,17,22H,5,15-16H2,1-3H3,(H,34,35)(H,30,31,32)/t22-/m1/s1 | Definition date: | 2021-01-25 | Last modified: | 2021-10-08 | Release date: | 2021-10-13 | Identifier: | (2~{R})-2-[[7-but-2-ynyl-5-(3-chloranyl-2-methyl-phenyl)-6-ethyl-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-3-phenyl-propanoic acid |
|
![U6Q U6Q](https://data.pdbj.org/pdbjplus/data/cc/svg/U6Q.svg) | U6Q | Name: | (2~{R})-2-[[5-(3-chloranyl-2-methyl-phenyl)-6-ethyl-thieno[2,3-d]pyrimidin-4-yl]amino]-3-phenyl-propanoic acid | Formula: | C24 H22 Cl N3 O2 S | SMILES: | CCc1sc2ncnc(N[CH](Cc3ccccc3)C(O)=O)c2c1c4cccc(Cl)c4C | InChi: | InChI=1S/C24H22ClN3O2S/c1-3-19-20(16-10-7-11-17(25)14(16)2)21-22(26-13-27-23(21)31-19)28-18(24(29)30)12-15-8-5-4-6-9-15/h4-11,13,18H,3,12H2,1-2H3,(H,29,30)(H,26,27,28)/t18-/m1/s1 | Definition date: | 2021-01-25 | Last modified: | 2021-10-08 | Release date: | 2021-10-13 | Identifier: | (2~{R})-2-[[5-(3-chloranyl-2-methyl-phenyl)-6-ethyl-thieno[2,3-d]pyrimidin-4-yl]amino]-3-phenyl-propanoic acid |
|
![U6T U6T](https://data.pdbj.org/pdbjplus/data/cc/svg/U6T.svg) | U6T | Name: | 4-(6-aminopurin-9-yl)-~{N}-[4-(trifluoromethylsulfonyl)phenyl]cyclohexane-1-carboxamide | Formula: | C19 H19 F3 N6 O3 S | SMILES: | Nc1ncnc2n(cnc12)[CH]3CC[CH](CC3)C(=O)Nc4ccc(cc4)[S](=O)(=O)C(F)(F)F | InChi: | InChI=1S/C19H19F3N6O3S/c20-19(21,22)32(30,31)14-7-3-12(4-8-14)27-18(29)11-1-5-13(6-2-11)28-10-26-15-16(23)24-9-25-17(15)28/h3-4,7-11,13H,1-2,5-6H2,(H,27,29)(H2,23,24,25)/t11-,13+ | Definition date: | 2021-01-25 | Last modified: | 2021-10-08 | Release date: | 2021-10-13 | Identifier: | 4-(6-aminopurin-9-yl)-~{N}-[4-(trifluoromethylsulfonyl)phenyl]cyclohexane-1-carboxamide |
|